Jump to Navigation Jump to Content
Home
  • Facebook
  • Twitter
  • YouTube
  • Home
  • Français
  • Contact Us
Centre de distribution de CATIE
  • Hepatitis C
  • Subscriptions
  • Become a Member
Home » Treatment » Treatment Update » TreatmentUpdate 215
  • The Basics
  • Prevention
  • Treatment
  • Healthy Living
  • Strengthening Programming
  • What's New?
  • About CATIE
  • eduCATIE Courses

Treatment

  • TreatmentUpdate
  • HIV Treatments
  • Hepatitis C Treatments
  • Treating HIV and Hepatitis C Co-infection
  • HIV-related Infections and Other Health Conditions
  • Paying for Treatment

Latest Blog Posts

  • Making OraQuick quicker: The VIRCAN 5-Minute Rule

  • What do online users want from HIV/STI risk calculators?

  • Four questions with the Manitoba HIV/STBBI Collective Impact Network

More

 

TreatmentUpdate
215
  • See all issues of TreatmentUpdate
  • Subscribe

May/June 2016 

  • Print-friendly PDF

Table of Contents

  • Anti-hepatitis C drugs
    • New drugs, wider range of genotypes, more cures
    • Know your drugs and classes
    • When HCV treatment failure occurs
    • Child-Turcotte-Pugh – Grading severe liver disease and the likelihood of survival
    • ABT-493 + ABT-530 – Eight-week treatment in genotypes 1 or 2 without cirrhosis
    • ABT-493 + ABT-530 in genotype 3 with cirrhosis
    • ABT-493 + ABT-530 – Eight-week treatment in genotype 3 without cirrhosis
    • ABT-493 + ABT-530 in genotypes 4, 5 and 6
    • ABT-493 + ABT-530 in genotype 1 with previous DAA therapy failure
    • France – Events after cure of HCV
    • U.S. study looks at long-term durability of cure, risk of relapse and liver cancer

News

Screening alcohol and substance use may ultimately help improve PrEP adherence

Can the CD4/CD8 ratio be used to predict the risk of anal cancer in HIV-positive people?

Can psilocybin and psychotherapy help relieve distress in long-term AIDS survivors?

Studying patterns of healthy aging among HIV-positive people in Canada

More

CATIE Announces

Webinar: The evolution of HIV treatment: Then and now
February 4, 2021
12:00 pm - 1:30 pm EST

CATIE 1990/2020 - Chapter One: The Treatment Information Exchange

CATIE 1990/2020 - Chapter Two: The HIV Treatment Evolution

CATIE 1990/2020 - Chapter Three: The HIV Prevention Revolution

CATIE 1990/2020 - Chapter Four: Hepatitis C

More

Events

IAS COVID-19 Conference: Prevention

International AIDS Society
February 2, 2021
Online

À la croisée des identités

MIELS-Québec
February 17 and 18, 2021
Online

CAHR 2021

Canadian Association for HIV Research
May 5 to 7, 2021
Online

More

New Resources

TreatmentUpdate 238 (CATIE)

HIV in Canada: 2019 surveillance highlights (PHAC)

Estimates of HIV incidence, prevalence and Canada's progress on meeting the 90-90-90 HIV targets, 2018 (PHAC)

HIV self-testing (CATIE)

Managing Your Health During the COVID-19 Pandemic: Information for people living with HIV (CATIE)

More

CATIE: Canada's source for HIV and Hepatitis C information

English Footer Menu (Left)

  • Contact Us
  • Donate to CATIE
  • Funders
  • Statement on truth and reconciliation

English Footer Menu (Right)

  • Privacy
  • Disclaimer
  • Permission to Reproduce
  • Disability policy

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.


We comply with the HONcode standard for trustworthy health information: verify here.


Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.

This website is certified by Health On the Net Foundation. Click to verify.